ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 102 filers reported holding ANACOR PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $118,608,000 | -52.0% | 2,219,042 | +1.5% | 9.21% | -33.1% |
| Q4 2015 | $247,093,000 | -18.6% | 2,187,242 | -15.2% | 13.75% | -5.8% |
| Q3 2015 | $303,592,000 | +26.4% | 2,579,154 | -16.9% | 14.60% | +36.6% |
| Q2 2015 | $240,267,000 | +27.4% | 3,103,027 | -4.8% | 10.68% | +14.6% |
| Q1 2015 | $188,536,000 | +131.8% | 3,259,045 | +29.2% | 9.32% | +95.2% |
| Q4 2014 | $81,329,000 | +57.0% | 2,521,822 | +19.1% | 4.77% | +23.4% |
| Q3 2014 | $51,795,000 | +75.8% | 2,116,665 | +27.4% | 3.87% | +76.4% |
| Q2 2014 | $29,460,000 | -53.2% | 1,661,612 | -47.2% | 2.19% | -15.6% |
| Q1 2014 | $62,914,000 | +133.9% | 3,144,156 | +96.1% | 2.60% | +3.6% |
| Q4 2013 | $26,903,000 | +58.3% | 1,603,278 | +0.2% | 2.51% | +40.9% |
| Q3 2013 | $16,994,000 | +87.9% | 1,600,178 | -1.1% | 1.78% | +66.9% |
| Q2 2013 | $9,043,000 | – | 1,617,651 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |